Truth Seeker
New Member
Abstract
INTRODUCTION:
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease that frequently causes pain.
AREAS COVERED:
This article reviews the current literature and describes the therapeutic options for treating MS-related pain. The reader will be provided with current, evidence-based knowledge about the treatment of MS-related pain, and the review will take a practical approach to the various drugs for treating pain, including starting dose, titration and side effects.
EXPERT OPINION:
Only cannabinoids have been assessed in randomized, controlled trials. Because of the concern regarding the risk of abuse and psychiatric adverse events, published guidelines as well as expert recommendations suggest using them as second-line therapy only. Hence, current treatment should be based on the general principles for treating peripheral neuropathic pain, taking into account drug-induced adverse effects.
Source: Treating pain in multiple sclerosis. [Expert Opin Pharmacother. 2011] - PubMed - NCBI
INTRODUCTION:
Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease that frequently causes pain.
AREAS COVERED:
This article reviews the current literature and describes the therapeutic options for treating MS-related pain. The reader will be provided with current, evidence-based knowledge about the treatment of MS-related pain, and the review will take a practical approach to the various drugs for treating pain, including starting dose, titration and side effects.
EXPERT OPINION:
Only cannabinoids have been assessed in randomized, controlled trials. Because of the concern regarding the risk of abuse and psychiatric adverse events, published guidelines as well as expert recommendations suggest using them as second-line therapy only. Hence, current treatment should be based on the general principles for treating peripheral neuropathic pain, taking into account drug-induced adverse effects.
Source: Treating pain in multiple sclerosis. [Expert Opin Pharmacother. 2011] - PubMed - NCBI
